LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma
Molecular Carcinogenesis · 2026-07 · 65 (7) · 795-806
DOI: 10.1002/mc.70117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 08.04.2026. Verfasst von Yifan Wen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, RNA, Long Noncoding, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Foundation of Peking University School, Hospital of Stomatology.
Abstract (Originalsprache)
Small‐molecule MYC inhibitors that directly target MYC are considered attractive cancer therapeutics. Here, we demonstrate that LUCAT1, a long noncoding RNA, serves as a critical mediator of MYC‐driven signaling in head and neck squamous cell carcinoma (HNSCC). The LUCAT1 expression is significantly downregulated in HNSCC cells following treatment with the MYC inhibitor MYCi975. Mechanically, MYC transcriptionally activates LUCAT1 through direct promoter binding, facilitating oncogenic functions. Clinically, elevated LUCAT1 is linked to cervical lymph node involvement in HNSCC and is associated with unfavorable patient outcomes. Functional studies in vitro demonstrated that LUCAT1 knockdown inhibits proliferation, migratory capacity, and invasive activity of HNSCC cells. This suppression also extends to the in vivo growth of tumors. Importantly, LUCAT1 overexpression attenuates the MYCi975 anti‐tumor effects on HNSCC, confirming its role in therapeutic resistance. These results establish LUCAT1 as both a biomarker of aggressive disease and a mediator of MYC‐driven oncogenesis, proposing LUCAT1 as a candidate synergistic therapeutic target in the treatment of HNSCC with MYC inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
- National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China.
- Inner Mongolia Medical University, Hohhot, China.
ORCID-Profile: Yifan Wen, Lingfei Jia, Xin Peng
Förderung
- National Natural Science Foundation of China
- Research Foundation of Peking University School
- Hospital of Stomatology
Zitieren
APA
Wen, Y., Liu, S., Qin, Z., Cai, J., Jia, L., & Peng, X. (2026). LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma. Molecular Carcinogenesis, 65(7), 795-806. https://doi.org/10.1002/mc.70117
Vancouver
Wen Y, Liu S, Qin Z, Cai J, Jia L, Peng X. LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma. Molecular Carcinogenesis. 2026;65(7):795-806. doi:10.1002/mc.70117
BibTeX
@article{Wen2026,
author = {Wen, Yifan and Liu, Shuo and Qin, Zhen and Cai, Jingshu and Jia, Lingfei and Peng, Xin},
title = {LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma},
journal = {Molecular Carcinogenesis},
year = {2026},
volume = {65},
number = {7},
pages = {795--806},
doi = {10.1002/mc.70117}
}
EUVIMED